News Feature: Rituximab in Systemic Sclerosis? A recent metanalysis suggests that rituximab may improve skin score and disease activity indices (DAS, mRSS) while stabilizing organ involvement in SSc patients. https://t.co/lH7aP7ht10 https://t.co/UdV8NRHxdC